Riskpilot← Back to searchSign inGet full accessVallabrinks Tandvård AB
ABActiveOrg 5565882106Pinnmovägen 5Dental practice care activities · NACE 8623Est. 20004 employees
Revenue 2024
SEK 3,5M
-1% vs 2023
EBITDA margin
-2.8%
-118% vs 2023
Equity ratio
53.0%
Financial strength
Net profit 2024
SEK -270K
-185% vs 2023
| Revenue | SEK 3,5M | -1% |
| EBITDA | SEK -97K | -118% |
| Net profit | SEK -270K | -185% |
| Total assets | SEK 962K | -13% |
| Equity | SEK 510K | -35% |
| Employees | 4 | — |
Legal name
Vallabrinks Tandvård AB
Org number
5565882106
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
11 april 2000
Share capital
SEK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva dentalverksamhet via egen praktik med försäljning av tandvårdsprodukter samt IT-konsulting, försäljning av data-, tele-, navigations- och kommunikationsprodukter samt därmed förenlig verksamhet.
Address
Pinnmovägen 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 750 | 3 121 | 3 450 | 3 514 | 3 478 |
| Staff expenses | — | — | −1 344 | −1 418 | −2 311 |
| EBITDA | −134 | 424 | 636 | 528 | −97 |
| Depreciation & amort. | −74 | −97 | −103 | −123 | −171 |
| EBIT | −208 | 327 | 533 | 405 | −268 |
| Net financials | −2 | −2 | −0 | −1 | −2 |
| Profit before tax | −210 | 329 | 533 | 404 | −270 |
| Tax | −0 | −32 | −112 | −86 | — |
| Net profit | −210 | 297 | 421 | 318 | −270 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 404 | 679 | 758 | 1 105 | 962 |
| Equity | 120 | 417 | 461 | 780 | 510 |
| Long-term debt | 90 | 0 | — | — | — |
| Short-term debt | 195 | 262 | 297 | 325 | 452 |
| Total debt | 285 | 262 | 297 | 325 | 452 |
EBITDA margin
-2.8%
This company
15.8%
Market median
-118% vs market
20202024
Equity ratio
53.0%
This company
38.2%
Market median
+39% vs market
20202024
Return on equity
-53.0%
This company
18.4%
Market median
-388% vs market
20202024
Net profit margin
-7.8%
This company
8.1%
Market median
-196% vs market
20202024
Asset turnover
3.62×
This company
1.12×
Market median
+223% vs market
20202024
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vallabrinks Tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulla Helene Magnusson | Chief Executive Officer | 0 companies |
| Lars Erik Magnusson | Deputy Board Member | 0 companies |